Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibioti...

    2026-01-18

    Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Gram-Negative and Gram-Positive Bacteria

    Executive Summary: Meropenem trihydrate is a carbapenem antibiotic with broad-spectrum activity against gram-negative, gram-positive, and anaerobic pathogens, validated by low MIC90 values in standardized testing conditions (APExBIO). Its efficacy is modulated by pH, with increased antibacterial potency observed at pH 7.5. The primary mode of action is inhibition of bacterial cell wall synthesis through high-affinity binding to penicillin-binding proteins (PBPs) (Dixon et al., 2025). Meropenem trihydrate is highly soluble in water and DMSO but insoluble in ethanol, and is suitable for short-term solution stability at -20°C. In vivo models, including acute necrotizing pancreatitis in rats, demonstrate therapeutic efficacy and support further research integration.

    Biological Rationale

    Carbapenem antibiotics are regarded as last-resort agents for treating multidrug-resistant bacterial infections (Dixon et al., 2025). Meropenem trihydrate (SKU: B1217) is a β-lactam antibiotic that displays broad-spectrum antibacterial activity. This agent is effective against clinically relevant gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., Citrobacter spp., Proteus mirabilis, and Morganella morganii. It also targets gram-positive pathogens including Streptococcus pyogenes, viridans group streptococci, and Streptococcus pneumoniae (APExBIO). Meropenem trihydrate is valued in research for its stability against most β-lactamases and its utility in resistance mechanism studies (see comparative overview; this article details novel metabolomic insights and pH-dependence not covered in prior summaries).

    Mechanism of Action of Meropenem trihydrate

    Meropenem trihydrate inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), which are essential for peptidoglycan cross-linking. This binding disrupts the terminal stages of cell wall assembly, leading to bacterial cell lysis and death (APExBIO). The antibiotic's β-lactam ring structure confers resistance to most β-lactamase enzymes produced by bacteria, a key advantage over other β-lactam classes (compare with prior stability-focused review; this article adds pH-dependent activity parameters). Activity is optimal at physiological pH (7.5), and declines under acidic conditions (pH 5.5), which is relevant for infection models and in vivo environments. The trihydrate form ensures reproducible solubility in water and DMSO, supporting consistent dosing in experimental workflows.

    Evidence & Benchmarks

    • Meropenem trihydrate demonstrates low MIC90 values (≤0.25–2 μg/mL) against Escherichia coli and Klebsiella pneumoniae at pH 7.5, indicating high potency (APExBIO, product page).
    • Carbapenemase-producing Enterobacterales exhibit altered metabolomic signatures, supporting the use of meropenem in resistance profiling workflows (Dixon et al., 2025).
    • In acute necrotizing pancreatitis rat models, meropenem trihydrate reduces hemorrhage, fat necrosis, and pancreatic infection, especially when combined with deferoxamine (APExBIO).
    • Solubility benchmarks: ≥20.7 mg/mL in water (with gentle warming), ≥49.2 mg/mL in DMSO; insoluble in ethanol (APExBIO, B1217 kit).
    • Short-term solution stability is optimal at -20°C, with solutions intended for immediate use to preserve activity (APExBIO, storage guidelines).
    • Carbapenem resistance in Enterobacterales is primarily mediated by carbapenemase enzymes, efflux pumps, and porin mutations (Dixon et al., 2025).

    Applications, Limits & Misconceptions

    Meropenem trihydrate is intended for scientific research applications. It is extensively used in:

    Common Pitfalls or Misconceptions

    • Meropenem trihydrate is not intended for diagnostic or clinical therapeutic use (research use only).
    • Acidic environments (pH ≤ 5.5) significantly reduce antibacterial activity; results at low pH may not reflect physiological efficacy.
    • It is ineffective against strains with high-level carbapenemase production (e.g., OXA-48-like enzymes), which can hydrolyze carbapenems (Dixon et al., 2025).
    • Improper storage (above -20°C) or long-term solution storage can lead to degradation and loss of activity.
    • It is insoluble in ethanol; attempting dissolution in ethanol will result in precipitation and dosing errors.

    Workflow Integration & Parameters

    For optimal results, reconstitute Meropenem trihydrate in water (≥20.7 mg/mL with gentle warming) or DMSO (≥49.2 mg/mL). Prepare solutions fresh or store at -20°C for short-term use. Adjust pH to 7.2–7.5 for most in vitro assays to maximize activity. Avoid repeated freeze-thaw cycles. For metabolomics-guided resistance profiling, combine with LC-MS/MS or MALDI-TOF MS workflows (compare with protocol guide; this article adds metabolomics-driven parameterization). For in vivo infection models, dose according to body weight and monitor endpoints such as bacterial clearance and inflammatory markers. Always consult the APExBIO product page for the latest specifications and safety data.

    Conclusion & Outlook

    Meropenem trihydrate remains a cornerstone of antibacterial research due to its robust activity against a broad bacterial spectrum and its role in resistance phenotyping. pH-dependent efficacy and β-lactamase stability are key features for experimental design. Continued integration with metabolomics and rapid diagnostic workflows is anticipated to refine resistance mechanism studies and accelerate translational research. For further reading on advanced mechanisms and translational applications, see this deep-dive article (this overview emphasizes pH and workflow integration parameters not previously detailed).